Skip to content
Screener

Maravai LifeSciences Holdings, Inc. MRVI Q1 2026 earnings

Reported May 7, 2026 · After market close

Revenue$65.8MBeat by $12.8M
EPS$0.01Beat by $0.06
Revenue estimate$53.0M
EPS estimate-$0.05

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$43.7M
EPS estimate-$0.06

Financials

Q1 2026

Income statement

See full
Revenue$65.8M+40.5%
Gross profit$33.7M+336%
Operating income-$2.2M+95.6%
Net income-$3.7M+87.5%
EPS (diluted)-$0.02+90.5%

Balance sheet

See full
Cash & equivalents$165.9M-41.8%
Total debt$270.9M-17.1%
Total equity$211.6M-29.6%
Total assets$713.2M-25.7%

Cash flow

See full
Operating cash flow$8.7M+192%
CapEx$4.4M-1.4%
Free cash flow$4.2M+130%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$414.26M+30.5%
Enterprise value$519.22M+44.6%
P/S2×+0.7×

Profitability

See full
Gross margin29.3%-8.0pp
Operating margin-82.2%-16.6pp
Net margin-51.1%-9.9pp
FCF margin-25.7%—

Returns & leverage

See full
Return on equity-40.8%-4.0pp
Debt / equity1.3×+0.2×
Current ratio5.9×-0.1×

Segments

By geography

See full
Europe, the Middle East and Africa$21.9M+219%
Asia Pacific$7.9M-25.4%
Latin and Central America$329.0K+125%

FAQ

When did Maravai LifeSciences Holdings, Inc. report Q1 2026 earnings?
Maravai LifeSciences Holdings, Inc. (MRVI) reported Q1 2026 earnings on May 7, 2026 after market close.
What were Maravai LifeSciences Holdings, Inc.'s Q1 2026 revenue and EPS?
Maravai LifeSciences Holdings, Inc. reported revenue of $65.8M and eps of $0.01 for Q1 2026.
Did Maravai LifeSciences Holdings, Inc. beat estimates in Q1 2026?
Revenue beat the consensus estimate of $53.0M by $12.8M. EPS beat the consensus estimate of $-0.05 by $0.06.
How did Maravai LifeSciences Holdings, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 40.4% from $46.9M a year earlier.
Where can I find Maravai LifeSciences Holdings, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001823239-26-000022) and the 10-Q periodic report (0001823239-26-000024) directly on SEC EDGAR. The filing index links above go to sec.gov.